NEWS

NEWS TYPE
RELEASE YEAR

EVENT

[Open Seminar] Tsutomu Suzuki, Ph.D.

September 11, 2024

September 11, 2024

Keio University Human Biology-Microbiome-Quantum Research Center (WPI-Bio2Q) held an open seminar as follows:

Date & Time Tuesday, September 10, 2024, 16:00 -17:30
Venue 1F Lounge, Center for Integrated Medical Research, Shinanomachi Campus, Keio University (Onsite only)
Title RNA Modifications in Health and Disease
Speaker Tsutomu Suzuki, Ph.D.
Professor, Department of Chemistry and Biotechnology, University of Tokyo
Language English

Abstract

RNA molecules frequently undergo post-transcriptional modifications, which are essential for their proper function. To date, about 150 different types of chemical modifications have been identified in various RNA molecules across all domains of life. There are still a number of novel modifications to be discovered. RNA modifications appear to confer chemical diversities to simple RNA molecules basically composed of four letters, to acquire a greater variety of biological functions. These modifications play critical roles in stability and functions of RNA molecules. The physiological importance of RNA modification has been demonstrated by human diseases caused by aberrant RNA modification. We reported a severe reduction in the frequency of tRNA modifications in mitochondrial disease patients, like MELAS and MERRF. These findings provided the first evidence of RNA modification disorder. We have termed “RNA modopathy” as a new category of human diseases.

Queuosine (Q), a tRNA modification characterized by a 7-deazaguanosine with a bulky side chain, is widely present in both bacteria and eukaryotes. Unique to this modification, the free base of Q, known as queuine, is incorporated through a base replacement reaction, converting guanine (G) to Q. Eukaryotes, including humans, cannot synthesize queuine and must obtain it as a dietary nutrient from gut microbiota or dietary sources. In humans and other vertebrates, Q can be further modified by glycosylation, forming either galactosyl-queuosine (galQ) or mannosyl-queuosine (manQ). The function of these glycosylated Q modifications remained unclear for nearly half a century after their discovery. Recently, we identified two glycosyltransferases responsible for the formation of galQ and manQ and elucidated the biosynthesis, functional roles in protein synthesis, and physiological significance of these glycosylated Q tRNA modifications.

More Bio2Q News

EVENT
2025.06.20

【Seminar】WPI-Bio2Q Open Seminar: Tomoe Ishikawa, Ph.D.(for Keio Members)

Keio University Human Biology-Microbiome-Quantum Research Center (WPI-Bio2Q) will hold a seminar as follows. This is an event only for facu...

ANNOUNCEMENT
2025.06.18

New Member - Dr. Leonie Brockmann

Introducing new member of Bio2Q We are delighted to welcome Dr. Leonie  as a Jr. PI at Bio-1 Core of Bio2Q. "The gut immune system perfo...

ANNOUNCEMENT
2025.06.10

New Member - Dr. Scott Behie

Introducing new member of Bio2Q We are excited to welcome Dr. Scott Behie as a Director of Research Programs of Bio2Q. "Hello everyone! I’...

ANNOUNCEMENT
2025.06.09

Call for full-time Technical Staff for Professor Nadinath Nillegoda’s Lab

Professor Nadinath Nillegoda’s Lab is currently hiring a technical staff for FY2025. We look forward to receiving applications from candi...

EVENT
2025.06.09

The 2nd WPI-Bio2Q Retreat (June 5-6, 2025)

The Keio University Human Biology-Microbiome-Quantum Research Center (WPI-Bio2Q) held the second WPI-Bio2Q Retreat on June 5 and 6 in Shuzen...